CN101472565B - 颗粒剂的制备方法 - Google Patents
颗粒剂的制备方法 Download PDFInfo
- Publication number
- CN101472565B CN101472565B CN2007800223582A CN200780022358A CN101472565B CN 101472565 B CN101472565 B CN 101472565B CN 2007800223582 A CN2007800223582 A CN 2007800223582A CN 200780022358 A CN200780022358 A CN 200780022358A CN 101472565 B CN101472565 B CN 101472565B
- Authority
- CN
- China
- Prior art keywords
- viscosity
- master batch
- preparing
- chinese medicine
- spray
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims description 36
- 239000000203 mixture Substances 0.000 title claims description 23
- 238000009472 formulation Methods 0.000 title description 3
- 239000008187 granular material Substances 0.000 claims abstract description 42
- 239000002002 slurry Substances 0.000 claims abstract description 32
- 239000012530 fluid Substances 0.000 claims abstract description 19
- 239000000725 suspension Substances 0.000 claims abstract description 17
- 239000002245 particle Substances 0.000 claims description 75
- 239000003814 drug Substances 0.000 claims description 59
- 238000000034 method Methods 0.000 claims description 55
- 239000004594 Masterbatch (MB) Substances 0.000 claims description 51
- 239000003795 chemical substances by application Substances 0.000 claims description 44
- 239000007921 spray Substances 0.000 claims description 43
- 239000000463 material Substances 0.000 claims description 34
- 239000000243 solution Substances 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- 239000000284 extract Substances 0.000 claims description 28
- 239000000843 powder Substances 0.000 claims description 25
- 239000003085 diluting agent Substances 0.000 claims description 23
- 239000003937 drug carrier Substances 0.000 claims description 21
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 19
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 19
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 19
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 17
- 239000000741 silica gel Substances 0.000 claims description 17
- 229910002027 silica gel Inorganic materials 0.000 claims description 17
- 239000007787 solid Substances 0.000 claims description 17
- 210000000589 cicatrix Anatomy 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 12
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 11
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 11
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 9
- 229920001661 Chitosan Polymers 0.000 claims description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 8
- 238000010410 dusting Methods 0.000 claims description 7
- 238000001704 evaporation Methods 0.000 claims description 7
- 230000008020 evaporation Effects 0.000 claims description 7
- 239000000470 constituent Substances 0.000 claims description 6
- -1 hydroxypropyl Chemical group 0.000 claims description 4
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 239000004034 viscosity adjusting agent Substances 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 33
- 239000011248 coating agent Substances 0.000 description 30
- 238000000576 coating method Methods 0.000 description 30
- 229920002472 Starch Polymers 0.000 description 18
- 239000008107 starch Substances 0.000 description 18
- 235000019698 starch Nutrition 0.000 description 18
- 229920001353 Dextrin Polymers 0.000 description 15
- 239000004375 Dextrin Substances 0.000 description 15
- 235000019425 dextrin Nutrition 0.000 description 15
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 13
- 229960004756 ethanol Drugs 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- 229920003081 Povidone K 30 Polymers 0.000 description 10
- 239000002775 capsule Substances 0.000 description 10
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 9
- 239000011230 binding agent Substances 0.000 description 7
- 230000035922 thirst Effects 0.000 description 7
- 238000010791 quenching Methods 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000000171 quenching effect Effects 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 230000001476 alcoholic effect Effects 0.000 description 4
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 239000004368 Modified starch Substances 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 239000007931 coated granule Substances 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 239000003405 delayed action preparation Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 235000011868 grain product Nutrition 0.000 description 2
- 239000001341 hydroxy propyl starch Substances 0.000 description 2
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000005563 spheronization Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 241000218176 Corydalis Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241000217407 Margaritifera Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007800223582A CN101472565B (zh) | 2006-06-23 | 2007-06-22 | 颗粒剂的制备方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2006100144094A CN101091725A (zh) | 2006-06-23 | 2006-06-23 | 一种中药颗粒及其制备方法 |
CN200610014409.4 | 2006-06-23 | ||
PCT/CN2007/001960 WO2008000166A1 (fr) | 2006-06-23 | 2007-06-22 | Granulé et son procédé de préparation |
CN2007800223582A CN101472565B (zh) | 2006-06-23 | 2007-06-22 | 颗粒剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101472565A CN101472565A (zh) | 2009-07-01 |
CN101472565B true CN101472565B (zh) | 2012-01-04 |
Family
ID=38845124
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2006100144094A Pending CN101091725A (zh) | 2006-06-23 | 2006-06-23 | 一种中药颗粒及其制备方法 |
CN2007800223582A Expired - Fee Related CN101472565B (zh) | 2006-06-23 | 2007-06-22 | 颗粒剂的制备方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2006100144094A Pending CN101091725A (zh) | 2006-06-23 | 2006-06-23 | 一种中药颗粒及其制备方法 |
Country Status (12)
Country | Link |
---|---|
US (1) | US8951568B2 (zh) |
EP (1) | EP2036543B1 (zh) |
JP (1) | JP5601835B2 (zh) |
KR (1) | KR20090032096A (zh) |
CN (2) | CN101091725A (zh) |
AU (1) | AU2007264289B2 (zh) |
CA (1) | CA2654414C (zh) |
DK (1) | DK2036543T3 (zh) |
HK (1) | HK1127746A1 (zh) |
RU (1) | RU2456980C2 (zh) |
WO (1) | WO2008000166A1 (zh) |
ZA (1) | ZA200900172B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102160872A (zh) * | 2010-02-23 | 2011-08-24 | 天津天士力制药股份有限公司 | 复方丹参滴丸胶囊 |
KR101481772B1 (ko) * | 2012-06-19 | 2015-01-14 | 주식회사 아리바이오 | 추출물을 고농도로 함유하는 과립 또는 환의 제조방법 |
CN104224726B (zh) * | 2013-06-17 | 2018-04-03 | 天士力医药集团股份有限公司 | 一种中药微丸的制备方法 |
FR3033792B1 (fr) * | 2015-03-20 | 2017-04-21 | Innov'ia 3I | Compositions pulverulentes d'un complexe entre un acide et un metal a haute teneur en composes organiques soufres et leur procede de preparation |
CN107875125B (zh) * | 2016-09-30 | 2021-11-09 | 天士力医药集团股份有限公司 | 一种中药配方颗粒及其制备方法 |
CN109394855B (zh) * | 2017-08-17 | 2021-10-22 | 湖北香连药业有限责任公司 | 一种香连颗粒、香连制剂及其制备方法和用途 |
CN110274963B (zh) * | 2018-03-13 | 2022-10-18 | 天士力医药集团股份有限公司 | 一种消渴清指纹图谱检测方法 |
CN114098052A (zh) * | 2020-08-31 | 2022-03-01 | 美乐家公司 | 包含灵芝的膳食补充剂组合物及其制备方法 |
CN114642645B (zh) * | 2020-12-18 | 2023-06-16 | 四川峨嵋山药业有限公司 | 一种柠檬烯胶囊批量生产的改进方法 |
CN112999172B (zh) * | 2021-03-26 | 2023-07-21 | 那生桑 | 矿物类蒙药粉配方颗粒及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1109779A (zh) * | 1995-01-25 | 1995-10-11 | 余练康 | 肝炎用药参柴颗粒的一步成型制粒方法 |
CN1736406A (zh) * | 2004-08-20 | 2006-02-22 | 中国人民解放军军事医学科学院毒物药物研究所 | 含巴戟天提取物的制剂的制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52102416A (en) * | 1976-02-19 | 1977-08-27 | Okawara Mfg | Granule making method of herb medicine and like |
DE2900304C3 (de) | 1979-01-05 | 1981-11-05 | Dr. H.Schmittmann Gmbh, 5620 Velbert | Saponinextraktprodukt sowie Verfahren zu seiner Herstellung |
JPH02167229A (ja) | 1988-09-01 | 1990-06-27 | Kureha Chem Ind Co Ltd | かわらたけ由来の蛋白多糖体の粒状製剤 |
PH30929A (en) * | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
JPH06192113A (ja) | 1992-09-25 | 1994-07-12 | Powrex:Kk | 生薬類の造粒方法および固形製剤 |
JP2656727B2 (ja) | 1994-05-17 | 1997-09-24 | 財団法人工業技術研究院 | 防湿性漢方顆粒製剤 |
BR9906712A (pt) * | 1998-07-17 | 2000-10-10 | Janssen Pharmaceutica Nv | Péletes que apresentam um núcleo revestido com um antifúngico e um polìmero |
AR020343A1 (es) * | 1998-11-24 | 2002-05-08 | Steigerwald Arzlneimittelwerk | Metodo para producir farmacos que contienen extractos de plantas en una forma solida de aplicacion. |
FR2790668B1 (fr) * | 1999-03-12 | 2002-07-26 | D B F | Granules contenant une substance vegetale et leur procede de preparation |
MXPA01011800A (es) * | 1999-05-17 | 2003-08-19 | D B F | Granulos que contienen una sustancia vegetal y procedimiento para prepararlos. |
EP1088789A3 (en) * | 1999-09-28 | 2002-03-27 | Heraeus Quarzglas GmbH & Co. KG | Porous silica granule, its method of production and its use in a method for producing quartz glass |
PE20030527A1 (es) * | 2001-10-24 | 2003-07-26 | Gruenenthal Chemie | Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen |
SI21402A (sl) * | 2003-02-12 | 2004-08-31 | LEK farmacevtska dru�ba d.d. | Obloženi delci in farmacevtske oblike |
KR20070084325A (ko) * | 2004-11-18 | 2007-08-24 | 브리스톨-마이어스 스큅 컴퍼니 | 익사베필론을 포함하는 장용성 코팅된 비드 및 그의 제조방법 |
EP2258350B1 (en) * | 2005-03-16 | 2014-12-24 | Takeda GmbH | Taste masked dosage form containing roflumilast |
-
2006
- 2006-06-23 CN CNA2006100144094A patent/CN101091725A/zh active Pending
-
2007
- 2007-06-22 EP EP07721533.3A patent/EP2036543B1/en active Active
- 2007-06-22 AU AU2007264289A patent/AU2007264289B2/en not_active Ceased
- 2007-06-22 DK DK07721533.3T patent/DK2036543T3/da active
- 2007-06-22 RU RU2009101111/15A patent/RU2456980C2/ru active
- 2007-06-22 KR KR1020097001360A patent/KR20090032096A/ko active Search and Examination
- 2007-06-22 JP JP2009515689A patent/JP5601835B2/ja active Active
- 2007-06-22 WO PCT/CN2007/001960 patent/WO2008000166A1/zh active Application Filing
- 2007-06-22 CN CN2007800223582A patent/CN101472565B/zh not_active Expired - Fee Related
- 2007-06-22 CA CA2654414A patent/CA2654414C/en not_active Expired - Fee Related
- 2007-06-22 US US12/306,371 patent/US8951568B2/en not_active Expired - Fee Related
-
2009
- 2009-01-08 ZA ZA2009/00172A patent/ZA200900172B/en unknown
- 2009-06-08 HK HK09105089.2A patent/HK1127746A1/xx unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1109779A (zh) * | 1995-01-25 | 1995-10-11 | 余练康 | 肝炎用药参柴颗粒的一步成型制粒方法 |
CN1736406A (zh) * | 2004-08-20 | 2006-02-22 | 中国人民解放军军事医学科学院毒物药物研究所 | 含巴戟天提取物的制剂的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101091725A (zh) | 2007-12-26 |
EP2036543A4 (en) | 2010-03-03 |
AU2007264289B2 (en) | 2012-07-19 |
KR20090032096A (ko) | 2009-03-31 |
ZA200900172B (en) | 2009-12-30 |
JP2009541226A (ja) | 2009-11-26 |
US8951568B2 (en) | 2015-02-10 |
EP2036543A1 (en) | 2009-03-18 |
EP2036543B1 (en) | 2014-04-23 |
HK1127746A1 (en) | 2009-10-09 |
DK2036543T3 (da) | 2014-05-12 |
WO2008000166A1 (fr) | 2008-01-03 |
US20100009000A1 (en) | 2010-01-14 |
CA2654414C (en) | 2016-08-02 |
AU2007264289A1 (en) | 2008-01-03 |
CA2654414A1 (en) | 2008-01-03 |
RU2456980C2 (ru) | 2012-07-27 |
CN101472565A (zh) | 2009-07-01 |
JP5601835B2 (ja) | 2014-10-08 |
RU2009101111A (ru) | 2010-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101472565B (zh) | 颗粒剂的制备方法 | |
CN101439076B (zh) | 一种含降香油的中药颗粒的制备方法 | |
CN101439063B (zh) | 一种含当归提取物的中药颗粒剂及其制备方法 | |
CN101439062B (zh) | 一种含穿心莲内酯的中药颗粒及其制备方法 | |
CN101439065B (zh) | 一种含三七提取物的中药颗粒及其制备方法 | |
CN101439107B (zh) | 一种含山楂提取物的中药颗粒及其制备方法 | |
CN101439084B (zh) | 一种含藿香提取物的中药颗粒及其制备方法 | |
CN101439087B (zh) | 一种含丹参提取物的中药颗粒及其制备方法 | |
CN101439041B (zh) | 一种含灯盏花素的中药颗粒及其制备方法 | |
CN101439126B (zh) | 一种含黄杨宁的中药颗粒及其制备方法 | |
CN101439082B (zh) | 一种含苦参提取物的中药颗粒及其制备方法 | |
CN101439122B (zh) | 一种含熟地黄提取物的中药颗粒及其制备方法 | |
CN101439078B (zh) | 一种含黄芪提取物的中药颗粒及其制备方法 | |
CN101439058B (zh) | 一种复方银杏的中药颗粒及其制备方法 | |
CN101439086B (zh) | 一种含丹参总酚酸的中药颗粒及其制备方法 | |
CN101439085B (zh) | 含藿香提取物的中药颗粒及其制备方法 | |
CN101439068B (zh) | 一种含水飞蓟素的中药颗粒及其制备方法 | |
CN101439099B (zh) | 一种含赤芍提取物的中药颗粒及其制备方法 | |
CN101439079B (zh) | 一种含黄芪总皂甙的中药颗粒的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white Patentee after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300402 Tianjin science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white Patentee before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 (city of the modern Chinese Medicine) Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd Address before: 300402 Tianjin science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white Patentee before: Tasly Pharmaceutical Group Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120104 Termination date: 20210622 |